Cargando…

Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid

Introduction: In recent research, orally administered cannabidiol (CBD) showed a relatively high incidence of somnolence in a pediatric population. Previous work has suggested that when CBD is exposed to an acidic environment, it degrades to Δ(9)-tetrahydrocannabinol (THC) and other psychoactive can...

Descripción completa

Detalles Bibliográficos
Autores principales: Merrick, John, Lane, Brian, Sebree, Terri, Yaksh, Tony, O'Neill, Carol, Banks, Stan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576596/
https://www.ncbi.nlm.nih.gov/pubmed/28861485
http://dx.doi.org/10.1089/can.2015.0004
_version_ 1783260211468828672
author Merrick, John
Lane, Brian
Sebree, Terri
Yaksh, Tony
O'Neill, Carol
Banks, Stan L.
author_facet Merrick, John
Lane, Brian
Sebree, Terri
Yaksh, Tony
O'Neill, Carol
Banks, Stan L.
author_sort Merrick, John
collection PubMed
description Introduction: In recent research, orally administered cannabidiol (CBD) showed a relatively high incidence of somnolence in a pediatric population. Previous work has suggested that when CBD is exposed to an acidic environment, it degrades to Δ(9)-tetrahydrocannabinol (THC) and other psychoactive cannabinoids. To gain a better understanding of quantitative exposure, we completed an in vitro study by evaluating the formation of psychoactive cannabinoids when CBD is exposed to simulated gastric fluid (SGF). Methods: Materials included synthetic CBD, Δ(8)-THC, and Δ(9)-THC. Linearity was demonstrated for each component over the concentration range used in this study. CBD was spiked into media containing 1% sodium dodecyl sulfate (SDS). Samples were analyzed using chromatography with UV and mass spectrometry detection. An assessment time of 3 h was chosen as representative of the maximal duration of exposure to gastric fluid. Results: CBD in SGF with 1% SDS was degraded about 85% after 60 min and more than 98% at 120 min. The degradation followed first-order kinetics at a rate constant of −0.031 min(−1) (R(2)=0.9933). The major products formed were Δ(9)-THC and Δ(8)-THC with less significant levels of other related cannabinoids. CBD in physiological buffer performed as a control did not convert to THC. Confirmation of THC formation was demonstrated by comparison of mass spectral analysis, mass identification, and retention time of Δ(9)-THC and Δ(8)-THC in the SGF samples against authentic reference standards. Conclusions: SGF converts CBD into the psychoactive components Δ(9)-THC and Δ(8)-THC. The first-order kinetics observed in this study allowed estimated levels to be calculated and indicated that the acidic environment during normal gastrointestinal transit can expose orally CBD-treated patients to levels of THC and other psychoactive cannabinoids that may exceed the threshold for a physiological response. Delivery methods that decrease the potential for formation of psychoactive cannabinoids should be explored.
format Online
Article
Text
id pubmed-5576596
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Mary Ann Liebert, Inc.
record_format MEDLINE/PubMed
spelling pubmed-55765962017-08-31 Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid Merrick, John Lane, Brian Sebree, Terri Yaksh, Tony O'Neill, Carol Banks, Stan L. Cannabis Cannabinoid Res Original Research Introduction: In recent research, orally administered cannabidiol (CBD) showed a relatively high incidence of somnolence in a pediatric population. Previous work has suggested that when CBD is exposed to an acidic environment, it degrades to Δ(9)-tetrahydrocannabinol (THC) and other psychoactive cannabinoids. To gain a better understanding of quantitative exposure, we completed an in vitro study by evaluating the formation of psychoactive cannabinoids when CBD is exposed to simulated gastric fluid (SGF). Methods: Materials included synthetic CBD, Δ(8)-THC, and Δ(9)-THC. Linearity was demonstrated for each component over the concentration range used in this study. CBD was spiked into media containing 1% sodium dodecyl sulfate (SDS). Samples were analyzed using chromatography with UV and mass spectrometry detection. An assessment time of 3 h was chosen as representative of the maximal duration of exposure to gastric fluid. Results: CBD in SGF with 1% SDS was degraded about 85% after 60 min and more than 98% at 120 min. The degradation followed first-order kinetics at a rate constant of −0.031 min(−1) (R(2)=0.9933). The major products formed were Δ(9)-THC and Δ(8)-THC with less significant levels of other related cannabinoids. CBD in physiological buffer performed as a control did not convert to THC. Confirmation of THC formation was demonstrated by comparison of mass spectral analysis, mass identification, and retention time of Δ(9)-THC and Δ(8)-THC in the SGF samples against authentic reference standards. Conclusions: SGF converts CBD into the psychoactive components Δ(9)-THC and Δ(8)-THC. The first-order kinetics observed in this study allowed estimated levels to be calculated and indicated that the acidic environment during normal gastrointestinal transit can expose orally CBD-treated patients to levels of THC and other psychoactive cannabinoids that may exceed the threshold for a physiological response. Delivery methods that decrease the potential for formation of psychoactive cannabinoids should be explored. Mary Ann Liebert, Inc. 2016-04-01 /pmc/articles/PMC5576596/ /pubmed/28861485 http://dx.doi.org/10.1089/can.2015.0004 Text en © John Merrick et al. 2016; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Original Research
Merrick, John
Lane, Brian
Sebree, Terri
Yaksh, Tony
O'Neill, Carol
Banks, Stan L.
Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid
title Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid
title_full Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid
title_fullStr Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid
title_full_unstemmed Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid
title_short Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid
title_sort identification of psychoactive degradants of cannabidiol in simulated gastric and physiological fluid
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576596/
https://www.ncbi.nlm.nih.gov/pubmed/28861485
http://dx.doi.org/10.1089/can.2015.0004
work_keys_str_mv AT merrickjohn identificationofpsychoactivedegradantsofcannabidiolinsimulatedgastricandphysiologicalfluid
AT lanebrian identificationofpsychoactivedegradantsofcannabidiolinsimulatedgastricandphysiologicalfluid
AT sebreeterri identificationofpsychoactivedegradantsofcannabidiolinsimulatedgastricandphysiologicalfluid
AT yakshtony identificationofpsychoactivedegradantsofcannabidiolinsimulatedgastricandphysiologicalfluid
AT oneillcarol identificationofpsychoactivedegradantsofcannabidiolinsimulatedgastricandphysiologicalfluid
AT banksstanl identificationofpsychoactivedegradantsofcannabidiolinsimulatedgastricandphysiologicalfluid